Pyxis Oncology (PYXS) Cash & Equivalents (2020 - 2026)
Pyxis Oncology's Cash & Equivalents came in at $18.86 million for Q2 2026, up 75.7% from $10.73 million a year earlier.
Powered by 
Analysis
Pyxis Oncology (PYXS) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Pyxis Oncology's Cash & Equivalents was $15.42 million, down 20.8% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 13.8% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $19.47 million in FY2024 (+101.5%), $9.66 million in FY2023 (-94.6%), $179.29 million in FY2022 (-34.7%) and $274.74 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q4 2024.
- Year-over-year, Cash & Equivalents increased in two of the last seven quarters, with growth averaging 0.1%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2024 (growth of 101.5%), and the weakest in Q4 2023 (a decline of 94.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Pyxis Oncology | 106.57 Mn | -158.48 Mn | - | 18.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.86 Mn |
| Dec 31, 2025 | 15.42 Mn |
| Sep 30, 2025 | 8.92 Mn |
| Jun 30, 2025 | 10.73 Mn |
| Mar 31, 2025 | 12.76 Mn |
| Dec 31, 2024 | 19.47 Mn |
| Sep 30, 2024 | 12.06 Mn |
| Jun 30, 2024 | 25.07 Mn |
| Mar 31, 2024 | 27.97 Mn |
| Dec 31, 2023 | 9.66 Mn |
| Sep 30, 2023 | 14.72 Mn |
| Jun 30, 2023 | 25.90 Mn |
| Mar 31, 2023 | 53.06 Mn |
| Dec 31, 2022 | 179.29 Mn |
| Sep 30, 2022 | 198.54 Mn |
| Jun 30, 2022 | 223.36 Mn |
| Mar 31, 2022 | 247.09 Mn |
| Dec 31, 2021 | 274.74 Mn |
| Sep 30, 2021 | 133.48 Mn |
| Jun 30, 2021 | 142.47 Mn |
API Access
Pyxis Oncology Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PYXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PYXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PYXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();